[氨柔比星治疗小细胞肺癌的研究进展] - Suppr

Suppr

超能文献

[Advances on treatment of small cell lung cancer with amrubicin].

作者信息

Lu Hongyang, Chen Lili, Cai Jufen, Ma Shenglin

机构信息

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2010 May;13(5):544-9. doi: 10.3779/j.issn.1009-3419.2010.05.30.

DOI:10.3779/j.issn.1009-3419.2010.05.30

PMID:20677657

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6000701/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f4b/6000701/cbe63a604246/zgfazz-13-5-544-1.jpg

相似文献

[Advances on treatment of small cell lung cancer with amrubicin].[氨柔比星治疗小细胞肺癌的研究进展]

Zhongguo Fei Ai Za Zhi. 2010 May;13(5):544-9. doi: 10.3779/j.issn.1009-3419.2010.05.30.

Small-cell lung cancer responds to amrubicin.小细胞肺癌对氨柔比星有反应。

Lancet Oncol. 2007 Jan;8(1):13. doi: 10.1016/s1470-2045(06)70997-4.

Amrubicin for non-small-cell lung cancer and small-cell lung cancer.氨柔比星用于非小细胞肺癌和小细胞肺癌。

Invest New Drugs. 2007 Oct;25(5):499-504. doi: 10.1007/s10637-007-9069-0. Epub 2007 Jul 13.

Thymic small cell carcinoma shows marked response to amrubicin.胸腺小细胞癌对氨柔比星表现出显著反应。

J Thorac Oncol. 2009 Jun;4(6):778. doi: 10.1097/JTO.0b013e3181a52e74.

Amrubicin for the treatment of advanced lung cancer.阿柔比星治疗晚期肺癌。

Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):171-80. doi: 10.1517/17425250802670508.

Long-term amrubicin chemotherapy for small-cell lung cancer.长期氨柔比星化疗治疗小细胞肺癌。

Anticancer Res. 2012 Apr;32(4):1423-7.

[A case of relapsed small-cell lung cancer successfully treated by administration of amrubicin].

Nihon Kokyuki Gakkai Zasshi. 2007 Dec;45(12):967-70.

[A case of small cell lung cancer under hemodialysis with chronic renal failure treated with amrubicin while measuring blood concentration of the drug].

Nihon Kokyuki Gakkai Zasshi. 2007 Apr;45(4):337-43.

Amrubicin monotherapy for elderly patients with previously treated lung cancer.氨柔比星单药治疗既往接受过治疗的老年肺癌患者。

Intern Med. 2010;49(17):1857-62. doi: 10.2169/internalmedicine.49.3606. Epub 2010 Sep 1.

Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific?氨柔比星治疗小细胞肺癌：疗效是否跨越太平洋？

J Thorac Oncol. 2007 Feb;2(2):160-5. doi: 10.1097/jto.0b013e31802f1cd9.

引用本文的文献

Efficacy of weekly amrubicin for refractory or relapsed non-small cell lung cancer: A protocol of systematic review and meta-analysis.每周一次氨柔比星治疗难治性或复发性非小细胞肺癌的疗效：系统评价与荟萃分析方案

Medicine (Baltimore). 2020 Jun 19;99(25):e20454. doi: 10.1097/MD.0000000000020454.

本文引用的文献

[Advance of treatment of small cell lung cancer in 2009 american society of clinical oncology annual meeting.].[2009年美国临床肿瘤学会年会小细胞肺癌治疗进展。]

Zhongguo Fei Ai Za Zhi. 2009 Sep 20;12(9):1047-50. doi: 10.3779/j.issn.1009-3419.2009.09.019.

Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin.用于小细胞肺癌治疗的新一代蒽环类药物：聚焦氨柔比星

Drug Des Devel Ther. 2009 Feb 6;2:189-92. doi: 10.2147/dddt.s3972.

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.一项关于氨柔比星（一种合成的 9-氨基蒽环类药物）治疗既往治疗过的肺癌患者的 II 期研究。

Lung Cancer. 2010 Jul;69(1):99-104. doi: 10.1016/j.lungcan.2009.09.012. Epub 2009 Oct 23.

A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405.一项关于氨柔比星联合卡铂治疗老年小细胞肺癌的 II 期临床研究：日本北部肺癌研究组试验 0405。

Ann Oncol. 2010 Apr;21(4):800-803. doi: 10.1093/annonc/mdp384. Epub 2009 Oct 13.

Amrubicin: a synthetic anthracyclin analogue in the treatment of extensive stage small cell lung cancer.氨柔比星：广泛期小细胞肺癌治疗中的一种合成蒽环类抗生素类似物。

Recent Pat Anticancer Drug Discov. 2009 Nov;4(3):241-5. doi: 10.2174/157489209789206850.

A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.一项针对既往未经治疗的广泛期小细胞肺癌患者的氨柔比星与卡铂的I期研究。

J Thorac Oncol. 2009 Jun;4(6):741-5. doi: 10.1097/JTO.0b013e3181a52946.

Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer.氨柔比星治疗难治性和复发性小细胞肺癌的疗效与安全性回顾性分析

Int J Clin Oncol. 2009 Feb;14(1):63-9. doi: 10.1007/s10147-008-0802-2. Epub 2009 Feb 20.

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.在既往接受过治疗的小细胞肺癌患者中比较氨柔比星与拓扑替康的随机II期试验：日本北部肺癌研究组试验0402

J Clin Oncol. 2008 Nov 20;26(33):5401-6. doi: 10.1200/JCO.2008.18.1974. Epub 2008 Oct 14.

Dose escalation study of amrubicin in combination with fixed-dose irinotecan in patients with extensive small-cell lung cancer.氨柔比星联合固定剂量伊立替康治疗广泛期小细胞肺癌的剂量递增研究。

Oncology. 2008;74(1-2):7-11. doi: 10.1159/000138350. Epub 2008 Jun 9.

Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancer.

J Thorac Oncol. 2007 Aug;2(8):741-4. doi: 10.1097/JTO.0b013e31811f46f0.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验